Carbios SA (FR:ALCRB)
:ALCRB
Want to see FR:ALCRB full AI Analyst Report?
ALCRB Stock Chart & Stats
€10.37
€0.33(5.00%)
At close: 4:00 PM EST
€10.37
€0.33(5.00%)
Day’s Range― - ―
52-Week Range€5.02 - €15.84
Previous CloseN/A
Volume21.76K
Average Volume (3M)54.14K
Market Cap
€105.30M
Enterprise Value€76.42M
Total Cash (Recent Filing)€71.70M
Total Debt (Recent Filing)€44.85M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.29
Shares Outstanding16,905,630
10 Day Avg. Volume34,450
30 Day Avg. Volume54,144
Financial Highlights & Ratios
PEG Ratio-1.81
Price to Book (P/B)0.97
Price to Sales (P/S)60.79
P/FCF Ratio-10.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.12
Revenue Forecast (FY)€5.30M
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetCarbios’ equity base (~€193.8M) versus minimal debt (~€7.5M) provides substantial financial runway and lowers refinancing risk. This balance-sheet strength supports multi-quarter industrial roll-out, sustained R&D and partnership execution without immediate debt pressure.
Proprietary Enzymatic Technology & Diversified MonetizationOwning a proprietary enzymatic PET depolymerization process plus multiple commercialization paths (licensing, tech services, sale of plant outputs) creates a durable competitive position. Licensing scales with limited capex while services and plants validate execution and foster partner lock-in.
Early Commercial Traction (revenue Acceleration)A 433% revenue increase to ~€3.1M in 2025 signals nascent commercial traction and technology validation with industrial partners. While still early, sustained top-line acceleration is a durable indicator of adoption potential and supports scaling and licensing momentum over coming quarters.
Bears Say
Large Recurring Operating LossesLarge, recurring operating losses (EBIT ~-€25.9M; net ~-€34.3M) are a structural drag on value creation. Persistent negative profitability erodes equity over time, limits reinvestment capacity, and necessitates either sustained margin improvement or continued external capital to sustain operations.
Ongoing Negative Cash Flow / Cash BurnOperating cash flow and free cash flow remain negative (-€15.7M and -€18.4M in 2025). Persistent cash burn increases reliance on financing, constrains the company’s ability to fund capex for plants or commercialization, and raises dilution and execution risk over multiple funding cycles.
Small Absolute Revenue Base Despite GrowthDespite strong percentage growth, revenue is still only ~€3.1M in 2025. The small absolute base limits economies of scale, makes fixed industrial costs harder to absorb, and means achieving durable profitability depends on capital-intensive scaling and sustained commercial wins over many quarters.
Carbios SA News
ALCRB FAQ
What was Carbios SA’s price range in the past 12 months?
Carbios SA lowest stock price was €5.02 and its highest was €15.84 in the past 12 months.
What is Carbios SA’s market cap?
Carbios SA’s market cap is €105.30M.
When is Carbios SA’s upcoming earnings report date?
Carbios SA’s upcoming earnings report date is Sep 24, 2026 which is in 97 days.
How were Carbios SA’s earnings last quarter?
Currently, no data Available
Is Carbios SA overvalued?
According to Wall Street analysts Carbios SA’s price is currently Overvalued.
Does Carbios SA pay dividends?
Carbios SA does not currently pay dividends.
What is Carbios SA’s EPS estimate?
Carbios SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Carbios SA have?
Carbios SA has 16,905,630 shares outstanding.
What happened to Carbios SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Carbios SA?
Currently, no hedge funds are holding shares in FR:ALCRB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Carbios SA
Carbios SAS, a pioneering French green chemistry company, is at the forefront of developing industrial bioprocesses for the biodegradation and biorecycling of various polymers. Among its key innovations is EVANESTO, an enzymatic solution specifically designed to break down single-use plastics made from polylactic acid (PLA). The company also specializes in the enzymatic recycling of polyethylene terephthalate (PET). Furthermore, Carbios champions PLA, a biosourced and biodegradable plastic polymer widely employed in sectors like food packaging, disposable tableware, electronics, and medical applications. A fundamental objective is to transform plastic waste back into valuable, reusable plastic materials. Its innovative solutions are not limited to France but are also exported internationally. Notably, Carbios SAS maintains a crucial development agreement with Novozymes for the production of enzymes vital to recycling PET plastics and fibers. Established in 2011, Carbios SAS operates from its headquarters in Saint-Beauzire, France.
Technical Analysis
Options Prices
Currently, No data available
---